4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000950170-25-009815
Options or other derivatives
- Principal Accounting Officer acquired 76,120 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Tourangeau Greg · Principal Accounting Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-24 | Grant or award : show line 1 in the form Stock Option (right to buy) | +76,120 | 76,120 | D |
Loading xslF345X05/ownership.xml…